Financials in USD. Standardized financial statements.
A compact view of how Solventum Corporation turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue? | $8.32B | $8.25B | $8.20B | $8.13B | $8.17B | $7.28B |
| Revenue Growth? | +0.9% | +0.7% | +0.8% | -0.5% | +12.2% | 0.0% |
| Cost of Revenue? | $3.87B | $3.66B | $3.50B | $3.44B | $3.25B | $2.97B |
| Gross Profit? | $4.45B | $4.59B | $4.69B | $4.70B | $4.92B | $4.32B |
| Gross Margin? | +53.5% | +55.6% | +57.3% | +57.7% | +60.2% | +59.3% |
| Operating Expenses? | $2.27B | $3.56B | $3.00B | $3.00B | $3.04B | $2.88B |
| Operating Income? | $2.18B | $1.04B | $1.69B | $1.69B | $1.88B | $1.43B |
| EBITDA? | $2.55B | $1.53B | $2.23B | $2.27B | $2.48B | $2.03B |
| Income Before Tax | $1.71B | $605.00M | $1.67B | $1.69B | $1.88B | $1.44B |
| Income Tax Expense | $157.00M | $127.00M | $321.00M | $349.00M | $422.00M | $302.00M |
| Net Income? | $1.56B | $479.00M | $1.35B | $1.34B | $1.46B | $1.14B |
| EPS? | $8.94 | $2.77 | $7.79 | $7.79 | $8.47 | $6.60 |
| Diluted EPS? | $8.88 | $2.76 | $7.79 | $7.79 | $8.47 | $6.60 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality